Randomized, placebo-controlled trial of tolvaptan, a novel V2-receptor antagonist, in hyponatremia: Results of the SALT 2 trial with emphasis on efficacy and safety in cirrhosis

被引：0

作者：

Afdhal, N

Cardenas, A

Gines, P

Gross, P

Verbalis, J

Berl, T

Schrier, R

Bichet, D

Wagoner, L

Ouyang, J

Orlandi, C

Czerwiec, F

机构：

[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[2] Univ Barcelona, E-08007 Barcelona, Spain

[3] Univ Kliniikum Carl Gustav Carus Dresden, Dresden, Germany

[4] Georgetown Univ, Med Ctr, Washington, DC 20057 USA

[5] Univ Colorado, Hlth Sci Ctr, Denver, CO USA

[6] Hop Sacre Coeur, Montreal, PQ H4J 1C5, Canada

[7] Univ Cincinnati, Heart & Vasc Ctr, Cincinnati, OH 45221 USA

[8] Otsuka Maryland Res Inst, Rockville, MD USA

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：756A / 756A

页数：1